Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7468)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2014 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen H, Shen ZY, Xu W, Fan TY, Li J, Lu YF, Cheng ML, Liu J. Expression of P450 and nuclear receptors in normal and end-stage Chinese livers. World J Gastroenterol 2014; 20(26): 8681-8690 [PMID: 25024626 DOI: 10.3748/wjg.v20.i26.8681] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8681.htm |
| Number | Citing Articles |
| 1 |
Ai-Guo Wang, Ya-Nan Song, Jun Chen, Hui-Ling Li, Jian-Yi Dong, Hai-Peng Cui, Liang Yao, Xue-Feng Li, Wen-Ting Gao, Ze-Wen Qiu, Fu-Jin Wang, Jing-Yu Wang. Activation of RAS/ERK alone is insufficient to inhibit RXRα function and deplete retinoic acid in hepatocytes. Biochemical and Biophysical Research Communications 2014; 452(3): 801 doi: 10.1016/j.bbrc.2014.09.007
|
| 2 |
Lili Niu, Philipp E Geyer, Rajat Gupta, Alberto Santos, Florian Meier, Sophia Doll, Nicolai J Wewer Albrechtsen, Sabine Klein, Cristina Ortiz, Frank E Uschner, Robert Schierwagen, Jonel Trebicka, Matthias Mann. Dynamic human liver proteome atlas reveals functional insights into disease pathways. Molecular Systems Biology 2022; 18(5) doi: 10.15252/msb.202210947
|
| 3 |
Elsa Lilienberg, Ilse R. Dubbelboer, Amar Karalli, Rimma Axelsson, Torkel B. Brismar, Charlotte Ebeling Barbier, Agneta Norén, Frans Duraj, Mikael Hedeland, Ulf Bondesson, Erik Sjögren, Per Stål, Rickard Nyman, Hans Lennernäs. In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma. Molecular Pharmaceutics 2017; 14(2): 448 doi: 10.1021/acs.molpharmaceut.6b00886
|
| 4 |
|
| 5 |
Meng-Hui Zhang, Qin-Hai Shen, Zhao-Min Qin, Qiao-Ling Wang, Xi Chen. Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma. Oncology Letters 2016; 12(5): 3285 doi: 10.3892/ol.2016.5039
|
| 6 |
Dong Gui Hu, Shashikanth Marri, Ross A. McKinnon, Peter I. Mackenzie, Robyn Meech. Deregulation of the Genes that Are Involved in Drug Absorption, Distribution, Metabolism, and Excretion in Hepatocellular Carcinoma. Journal of Pharmacology and Experimental Therapeutics 2019; 368(3): 363 doi: 10.1124/jpet.118.255018
|
| 7 |
Naoko Takebe, Jan H. Beumer, Shivaani Kummar, Brian F. Kiesel, Afshin Dowlati, Geraldine O'Sullivan Coyne, Richard Piekarz, Lawrence Rubinstein, Laura K. Fogli, Ulka Vaishampayan, Sanjay Goel, Cindy L. O'Bryant, Bassel F. El‐Rayes, Vincent Chung, Heinz‐Josef Lenz, Richard Kim, Chandra P. Belani, Joseph M. Tuscano, William Schelman, Nancy Moore, James H. Doroshow, Alice P. Chen. A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. British Journal of Clinical Pharmacology 2019; 85(11): 2499 doi: 10.1111/bcp.14054
|
| 8 |
Sylwia Szeląg-Pieniek, Stefan Oswald, Mariola Post, Joanna Łapczuk-Romańska, Marek Droździk, Mateusz Kurzawski. Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure. Pharmacological Reports 2021; 73(5): 1427 doi: 10.1007/s43440-021-00290-8
|
| 9 |
Patrick C. Flannery, Kodye L. Abbott, Satyanarayana R. Pondugula. Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients. European Journal of Drug Metabolism and Pharmacokinetics 2020; 45(2): 297 doi: 10.1007/s13318-019-00595-3
|
| 10 |
Xianmei Lv, Gaochen Lan, Lujian Zhu, Qiusheng Guo. Breaking the Barriers of Therapy Resistance: Harnessing Ferroptosis for Effective Hepatocellular Carcinoma Therapy. Journal of Hepatocellular Carcinoma 2024; : 1265 doi: 10.2147/JHC.S469449
|
| 11 |
Xiaoning Gan, Yue Luo, Guanqi Dai, Junhao Lin, Xinhui Liu, Xiangqun Zhang, Aimin Li. Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00857
|
| 12 |
Kangning Zhu, Jing Li, Boya Chen, Xin Liu. A Bayesian-based Approach for Identification of Potential Protein Biomarkers in Hepatocellular Carcinoma. Proceedings of the 2023 15th International Conference on Bioinformatics and Biomedical Technology 2023; : 110 doi: 10.1145/3608164.3608214
|
| 13 |
Huan Li, Yuan-Fu Lu, Hong Chen, Jie Liu. Dysregulation of metallothionein and circadian genes in human hepatocellular carcinoma. Chronobiology International 2017; 34(2): 192 doi: 10.1080/07420528.2016.1256300
|
| 14 |
Jose J. G. Marin, Candela Cives-Losada, Maitane Asensio, Elisa Lozano, Oscar Briz, Rocio I. R. Macias. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma. Cancers 2019; 11(3): 407 doi: 10.3390/cancers11030407
|
| 15 |
Nan Hu, Yanjuan Huang, Xuejiao Gao, Sai Li, Zhixiang Yan, Bin Wei, Ru Yan. Effects of dextran sulfate sodium induced experimental colitis on cytochrome P450 activities in rat liver, kidney and intestine. Chemico-Biological Interactions 2017; 271: 48 doi: 10.1016/j.cbi.2017.04.018
|
| 16 |
Yoichi Sasaki, Ryotaro Sakamori, Ryoko Yamada, Minoru Shigekawa, Yuki Tahata, Yuki Makino, Tasuku Nakabori, Takahiro Kodama, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara. Cotreatment with lenvatinib and warfarin potassium caused prothrombin time prolongation. Hepatology Research 2019; 49(11): 1357 doi: 10.1111/hepr.13379
|
| 17 |
Wufeng Fan, Guangming Ye. Microarray analysis for the identification of specific proteins and functional modules involved in the process of hepatocellular carcinoma originating from cirrhotic liver. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8555
|
| 18 |
Joseph M. Collins, Danxin Wang. Cytochrome P450 3A4 (CYP3A4) protein quantification using capillary western blot technology and total protein normalization. Journal of Pharmacological and Toxicological Methods 2021; 112: 107117 doi: 10.1016/j.vascn.2021.107117
|
| 19 |
Basma Hossam Abdelmonem, Noha M. Abdelaal, Eman K. E. Anwer, Alaa A. Rashwan, Mohamed Ali Hussein, Yasmin F. Ahmed, Rana Khashana, Mireille M. Hanna, Anwar Abdelnaser. Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review. Biomedicines 2024; 12(7): 1467 doi: 10.3390/biomedicines12071467
|
| 20 |
J Xue, W Zhu, J Song, Y Jiao, J Luo, C Yu, J Zhou, J Wu, M Chen, W-Q Ding, J Cao, S Zhang. Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway. Oncogene 2018; 37(7): 953 doi: 10.1038/onc.2017.401
|
| 21 |
Xi Ma, Lin Zhou, Shusen Zheng. Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma. PeerJ 2020; 8: e8930 doi: 10.7717/peerj.8930
|
| 22 |
Jukun Wang, Ke Han, Chao Zhang, Xin Chen, Yu Li, Linzhong Zhu, Tao Luo. Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients. Bioscience Reports 2021; 41(5) doi: 10.1042/BSR20210583
|
| 23 |
Ming-Liang Cheng, Yuan-Fu Lu, Hong Chen, Zhong-Yang Shen, Jie Liu. Liver expression of Nrf2-related genes in different liver diseases. Hepatobiliary & Pancreatic Diseases International 2015; 14(5): 485 doi: 10.1016/S1499-3872(15)60425-8
|
| 24 |
Martin Krkoška, Jana Svobodová, Markéta Kabátková, Ondřej Zapletal, Alena Hyršlová Vaculová, Jana Nekvindová, Jan Vondráček. Deregulation of signaling pathways controlling cell survival and proliferation in cancer cells alters induction of cytochrome P450 family 1 enzymes. Toxicology 2021; 461: 152897 doi: 10.1016/j.tox.2021.152897
|
| 25 |
Jie Pan, Yuan Lu, Shuai Zhang, Yueting Li, Jia Sun, Hua Chunhua Liu, Zipeng Gong, Jing Huang, Chuang Cao, Yonglin Wang, Yongjun Li, Ting Liu. Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model rats. Xenobiotica 2020; 50(10): 1251 doi: 10.1080/00498254.2020.1765049
|
| 26 |
Sudhir Kumar, Jiang Wang, Richa Rani, Chandrashekhar R. Gandhi, Gianfranco Alpini. Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice. PLOS ONE 2016; 11(1): e0147864 doi: 10.1371/journal.pone.0147864
|
| 27 |
Xiaoyan Li, Yiyan Lu, Xiaojun Ou, Sijing Zeng, Ying Wang, Xiaoxiao Qi, Lijun Zhu, Zhongqiu Liu. Changes and sex- and age-related differences in the expression of drug metabolizing enzymes in a KRAS-mutant mouse model of lung cancer. PeerJ 2020; 8: e10182 doi: 10.7717/peerj.10182
|
| 28 |
Gargi Dixit, Arati Prabhu. The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics. Experimental and Molecular Pathology 2022; 124: 104723 doi: 10.1016/j.yexmp.2021.104723
|
| 29 |
Tongmeng Yan, Linlin Lu, Cong Xie, Jiamei Chen, Xiaojuan Peng, Lijun Zhu, Ying Wang, Qiang Li, Jian Shi, Fuyuan Zhou, Ming Hu, Zhongqiu Liu. Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients. Molecular Cancer Therapeutics 2015; 14(12): 2874 doi: 10.1158/1535-7163.MCT-15-0274
|
| 30 |
Jianqing Yu, Nuozhou Wang, Zhongqin Gong, Liping Liu, Shengli Yang, George Gong Chen, Paul Bo San Lai. Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma. Oncogene 2021; 40(3): 492 doi: 10.1038/s41388-020-01545-z
|
| 31 |
Florian Klomp, Christoph Wenzel, Marek Drozdzik, Stefan Oswald. Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes. Pharmaceutics 2020; 12(12): 1201 doi: 10.3390/pharmaceutics12121201
|
| 32 |
João Victor Dutra Gomes, Corinna Herz, Simone Helmig, Nadja Förster, Inga Mewis, Evelyn Lamy. Drug-Drug Interaction Potential, Cytotoxicity, and Reactive Oxygen Species Production of Salix Cortex Extracts Using Human Hepatocyte-Like HepaRG Cells. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.779801
|
| 33 |
Jianwai Ren, George G. Chen, Yi Liu, Xianwei Su, Baoguang Hu, Billy C. S. Leung, Y. Wang, Rocky L. K. Ho, Shengli Yang, Gang Lu, C. G. Lee, Paul B. S. Lai, Zhiyuan Gong. Cytochrome P450 1A2 Metabolizes 17β-Estradiol to Suppress Hepatocellular Carcinoma. PLOS ONE 2016; 11(4): e0153863 doi: 10.1371/journal.pone.0153863
|
| 34 |
Martin Krkoška, Jana Nekvindová, Kateřina Nevědělová, Veronika Zubáňová, Lenka Radová, Jan Vondráček, Jarmila Herůdková, Ondřej Slabý, Igor Kiss, Lucia Bohovicová, Pavel Fabian, Zuzana Tylichová, Zdeněk Kala, Petr Kysela, Lenka Ostřížková, Vladimír Palička, Alena Hyršlová Vaculová. Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma. Pharmacological Reports 2022; 74(1): 148 doi: 10.1007/s43440-021-00338-9
|
| 35 |
Yuseok Moon, Tamás Korcsmáros, Arulkumar Nagappan, Navin Ray. MicroRNA target-based network predicts androgen receptor-linked mycotoxin stress. Ecotoxicology and Environmental Safety 2022; 230: 113130 doi: 10.1016/j.ecoenv.2021.113130
|
| 36 |
Jiaqi Wang, Lushan Yu, Huidi Jiang, Xiaoli Zheng, Su Zeng. Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer. Drug Metabolism and Disposition 2020; 48(9): 759 doi: 10.1124/dmd.120.000008
|
| 37 |
Manuela G. Neuman, Stephen Malnick, Yaakov Maor, Radu M. Nanau, Ehud Melzer, Peter Ferenci, Helmut K. Seitz, Sebastian Mueller, Haim Mell, Didier Samuel, Lawrence B. Cohen, Kusum K. Kharbanda, Natalia A. Osna, Murali Ganesan, Kyle J. Thompson, Iain H. McKillop, Abraham Bautista, Ramon Bataller, Samuel W. French. Alcoholic liver disease: Clinical and translational research. Experimental and Molecular Pathology 2015; 99(3): 596 doi: 10.1016/j.yexmp.2015.09.001
|
| 38 |
X. Tang, L. Ge, Z. Chen, S. Kong, W. Liu, Y. Xu, S. Zeng, S. Chen. Methylation of the Constitutive Androstane Receptor Is Involved in the Suppression of CYP2C19 in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Drug Metabolism and Disposition 2016; 44(10): 1643 doi: 10.1124/dmd.116.070243
|
| 39 |
Haixing Li, Jed N. Lampe. Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism. Archives of Biochemistry and Biophysics 2019; 673: 108078 doi: 10.1016/j.abb.2019.108078
|
| 40 |
Yu-Jie Jiang, Ye-Ming Cao, Yong-Bing Cao, Tian-Hua Yan, Cheng-Lin Jia, Ping He. A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 2024; : 1511 doi: 10.2147/DMSO.S449494
|
| 41 |
Jana Nekvindova, Alena Mrkvicova, Veronika Zubanova, Alena Hyrslova Vaculova, Pavel Anzenbacher, Pavel Soucek, Lenka Radova, Ondrej Slaby, Igor Kiss, Jan Vondracek, Alena Spicakova, Lucia Bohovicova, Pavel Fabian, Zdenek Kala, Vladimir Palicka. Hepatocellular carcinoma: Gene expression profiling and regulation of xenobiotic-metabolizing cytochromes P450. Biochemical Pharmacology 2020; 177: 113912 doi: 10.1016/j.bcp.2020.113912
|
| 42 |
Yan Tan, Mina Wang, Ke Yang, Tiange Chi, Zehuan Liao, Peng Wei. PPAR-α Modulators as Current and Potential Cancer Treatments. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.599995
|
| 43 |
Ettore Mosca, Roberta Alfieri, Luciano Milanesi, Ranjit Ray. Diffusion of Information throughout the Host Interactome Reveals Gene Expression Variations in Network Proximity to Target Proteins of Hepatitis C Virus. PLoS ONE 2014; 9(12): e113660 doi: 10.1371/journal.pone.0113660
|
| 44 |
Jeong Eun Yoo, Ji Hae Nahm, Young-Joo Kim, Youngsic Jeon, Young Nyun Park. The dual role of transforming growth factor-beta signatures in human B viral multistep hepatocarcinogenesis: early and late responsive genes. Journal of Liver Cancer 2022; 22(2): 115 doi: 10.17998/jlc.2022.04.20
|
| 45 |
Xianqiang Zhou, Fang Tan, Suxian Zhang, An'an Wang, Tiansong Zhang. A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals
Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma. Current Pharmaceutical Design 2024; 30(5): 377 doi: 10.2174/0113816128284465240108071554
|
| 46 |
Maya Okamura, Ryota Shizu, Takuomi Hosaka, Takamitsu Sasaki, Kouichi Yoshinari. Possible involvement of the competition for the transcriptional coactivator glucocorticoid receptor-interacting protein 1 in the inflammatory signal-dependent suppression of PXR-mediated CYP3A induction in vitro. Drug Metabolism and Pharmacokinetics 2019; 34(4): 272 doi: 10.1016/j.dmpk.2019.04.005
|
| 47 |
Cheng-Lin Fu, Bing Pan, Ju-Hua Pan, Mei-Fu Gan. Metallothionein 1M suppresses tumorigenesis in hepatocellular carcinoma. Oncotarget 2017; 8(20): 33037 doi: 10.18632/oncotarget.16521
|
| 48 |
D. Desaulniers, N. Khan, C. Cummings-Lorbetskie, K. Leingartner, G-H. Xiao, A. Williams, C.L. Yauk. Effects of cross-fostering and developmental exposure to mixtures of environmental contaminants on hepatic gene expression in prepubertal 21 days old and adult male Sprague-Dawley rats. Journal of Toxicology and Environmental Health, Part A 2019; 82(1): 1 doi: 10.1080/15287394.2018.1542360
|
| 49 |
Hyuk Soo Eun, Sang Yeon Cho, Byung Seok Lee, Sup Kim, In‐Sang Song, Kwangsik Chun, Cheong‐Hae Oh, Min‐Kyung Yeo, Seok Hyun Kim, Kyung‐Hee Kim. Cytochrome P450 4A11 expression in tumor cells: A favorable prognostic factor for hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology 2019; 34(1): 224 doi: 10.1111/jgh.14406
|
| 50 |
Ruohao Zhang, Miao Huang, Hong Wang, Shengming Wu, Jiali Yao, Yingying Ge, Yufei Lu, Qiping Hu. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.597527
|
| 51 |
Christoph G Dietrich, Oliver Götze, Andreas Geier. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World Journal of Gastroenterology 2016; 22(1): 72-88 doi: 10.3748/wjg.v22.i1.72
|